The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival-Reference-Cited by-同舟云学术

The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival

Published:2017-06 Issue:7658 Volume:546 Page:426-430
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Wang Haizhen,Nicolay Brandon N.,Chick Joel M.,Gao Xueliang,Geng Yan,Ren Hong,Gao Hui,Yang Guizhi,Williams Juliet A.,Suski Jan M.,Keibler Mark A.,Sicinska Ewa,Gerdemann Ulrike,Haining W. Nicholas,Roberts Thomas M.,Polyak Kornelia,Gygi Steven P.,Dyson Nicholas J.,Sicinski Piotr

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature22797.pdf

Reference36 articles.

1. Malumbres, M. Cyclin-dependent kinases. Genome Biol. 15, 122 (2014)

2. Sherr, C. J., Beach, D. & Shapiro, G. I. Targeting CDK4 and CDK6: from discovery to therapy. Cancer Discov. 6, 353–367 (2016)

3. Deshpande, A., Sicinski, P. & Hinds, P. W. Cyclins and CDKs in development and cancer: a perspective. Oncogene 24, 2909–2915 (2005)

4. Dean, J. L., Thangavel, C., McClendon, A. K., Reed, C. A. & Knudsen, E. S. Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure. Oncogene 29, 4018–4032 (2010)

5. Puyol, M. et al. A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma. Cancer Cell 18, 63–73 (2010)

Cited by 261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beauvericin Reverses Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through Regulation of Notch Signaling and Autophagy;ACS Pharmacology & Translational Science;2024-09-03

2. ONCOLINER: A new solution for monitoring, improving, and harmonizing somatic variant calling across genomic oncology centers;Cell Genomics;2024-09

3. A chloroplast sulphate transporter modulates glutathione‐mediated redox cycling to regulate cell division;Plant, Cell & Environment;2024-08-27

4. Hernandezine acts as a CDK4 suppressor inhibiting tumor growth by the CDK4/PKM2/NRF2 axis in colon cancer;Phytomedicine;2024-08

5. MAZ-mediated up-regulation of BCKDK reprograms glucose metabolism and promotes growth by regulating glucose-6-phosphate dehydrogenase stability in triple-negative breast cancer;Cell Death & Disease;2024-07-18